Elfride De Baere

@elfridedebaere.bsky.social

Professor @UGent I Rare eye & developmental diseases I IRD I Retina & RPE I Non-coding variation I Multiomics I Targets for treatment debaerelab.com progret.eu

Retina Ex Vivo 2026 is just around the corner! 🧬 This FEBS course dives into organotypic retina cultures: 🔬 Day 1: Dissection, culture methods & ocular drug delivery (Keynote: Arto Urtti) 🧠 Day 2: Disease modeling (IRD, AMD, DR, glaucoma) 🧪 Day 3: Gene therapy, RNA tools & Keynote by K Palczewski

Our #ASHG25 platform activities: Vrathasha Vrathasha: 3D genomics & glaucoma. 206AB, W 10.45-11 Winter Bruner: MPRA & childhood obesity. 205ABC, T 11-11.15 Matt Pahl: Ancillary Session, Predicted Effector Genes. 259A, F 1.45-1.15 Struan Grant chairs Metabolic Matrix session. 253ABC, S 10-11

Bild

A great collaborative study of a novel adult-onset maculopathy that shows similarities with dry AMD with Eline Van Vooren, Filip Van den Broeck, Michael T. Redmond, Julie De Zaeytijd, Bart P. Leroy, Miriam Bauwens @elfridedebaere.bsky.social & many colleagues #RPE65 #dominant #maculopathy #AMD

@arvoiovs.bsky.social · 11mo ago

Elfride De Baere et al. from Ghent University find that a RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals. doi.org/10.1167/iovs.66.12.53